# Cullinan Therapeutics, Inc.: Form 8-K, filed Jun 12, 2025

- Company: [Cullinan Therapeutics, Inc.](/companies/cgem.md) (CIK 1789972)
- Form: 8-K
- Filed: 2025-06-12
- Accepted by EDGAR: Jun 12, 2025, 16:23 ET
- Period: 2025-06-12
- Accession: 0000950170-25-085425
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1789972/000095017025085425/cgem-20250612.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1789972/000095017025085425/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1789972/000095017025085425/cgem-20250612.htm

Filed Jun 12, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-085425. Last ingested by Listed: Nov 6, 2026, 18:08 ET. No prices; not investment advice.